A phase Ib window of opportunity study of atezolizumab administered intravesically or direct injection in patients undergoing radical cystectomy for bladder cancer: Results of the single dose cohorts.

Hussain, S.A., Oughton, J.B. orcid.org/0000-0002-2047-804X, Smith Whelan, R. et al. (11 more authors) (2025) A phase Ib window of opportunity study of atezolizumab administered intravesically or direct injection in patients undergoing radical cystectomy for bladder cancer: Results of the single dose cohorts. In: 2025 ASCO Genitourinary Cancers Symposium, 13-15 Feb 2025, San Francisco, CA.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
  • Hussain, S.A.
  • Oughton, J.B. ORCID logo https://orcid.org/0000-0002-2047-804X
  • Smith Whelan, R.
  • Green, A.
  • Riaz, I.B.
  • Hubbard, R.
  • Kennish, S.
  • McCready, D.
  • Griffin, J.
  • Senior, E.
  • Bowler, H.
  • Kendall, J.
  • Collinson, F.J.
  • Catto, J.W.F.
Dates:
  • Published (online): 18 February 2025
  • Published: 18 February 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 09 Jul 2025 10:49
Last Modified: 09 Jul 2025 10:49
Published Version: https://ascopubs.org/doi/10.1200/JCO.2025.43.5_sup...
Status: Published
Publisher: American Society of Clinical Oncology (ASCO)
Identification Number: 10.1200/jco.2025.43.5_suppl.773
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)